Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Systemic mastocytosis].

Olivier Fain1, Jerôme Stirnemann, Olivier Lortholary

  • 1Service de médecine interne, hôpital Jean Verdier, Université Paris XIII, 93140 Bondy. olivier.fain@jvr.aphp.fr

La Revue Du Praticien
|December 13, 2005
PubMed
Summary

Systemic mastocytosis involves abnormal mast cell growth in organs, leading to diverse symptoms. Treatment focuses on managing mediator release and reducing mast cell numbers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of care reorganisation during COVID-19 waves on non-COVID-19 inpatients in a Swiss hospital: a retrospective cohort study.

Swiss medical weekly·2026
Same author

The ICARUS project: study protocol for a randomised controlled trial Investigating aCute heArt failuRe decongestion guided by lung UltraSonography.

Trials·2026
Same author

Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulation.

Journal of internal medicine·2026
Same author

Overweight and obesity association with mortality in patients with heart failure and reduced or preserved ejection fraction-a cohort study.

PloS one·2026
Same author

[Selected novelties for hospital-based internal medicine].

Revue medicale suisse·2026
Same author

Association between critical care occupancy and code status decisions during resource scarcity: a retrospective cohort study.

BMC medical ethics·2025

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Context:

  • Systemic mastocytosis (SM) is a rare myeloproliferative neoplasm.
  • Characterized by abnormal mast cell proliferation and accumulation in various organs.
  • Classified into four distinct subtypes based on disease characteristics and severity.

Purpose:

  • To provide a comprehensive overview of systemic mastocytosis.
  • To detail the classification, clinical manifestations, diagnostic criteria, and therapeutic strategies for SM.

Summary:

  • SM involves mast cell proliferation, affecting organs like skin, bone, and liver.
  • Diagnosis relies on specific stains (Giemsa, Toluidine) and immunophenotyping (tryptase, CD117).
  • Treatment strategies include mediator release inhibition and cytoreductive therapies.

Impact:

  • Improved understanding of SM pathogenesis and clinical heterogeneity.
  • Guidance for accurate diagnosis and tailored treatment approaches.
  • Potential for enhanced patient management and outcomes in systemic mastocytosis.

Related Experiment Videos